MedTrace Logo

Post-COVID-19 Outpatient Care and Biomarkers

NCT05398952 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2022-06-08

No results posted yet for this study

Summary

The aims of this case-control, non-randomized study including patients with post-COVID-19 persisting symptoms are 1) to establish the large blood biobank, 2) to examine levels of circulating inflammatory biomarkers and different classes of non-coding RNAs (ncRNA), such as selected circRNAs and miRNAs, in plasma and serum samples collected from patients with post- COVID-19, 3) to test the levels of cfDNA in plasma and serum, 4) to define correlation between ncRNAs and cf-DNA with persistent clinical symptoms, and type of symptoms, and 5) to investigate diagnostic and prognostic performances of these circulating biomarkers.

Study design. This is a prospective registry including biobank.

Conditions

  • Post Viral Fatigue
  • Viral Myocarditis
  • POTS

Interventions

DIAGNOSTIC_TEST

Laboratory investigations

Laboratory investigations correlated with symptoms and imaging results

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Mariann Gyöngyösi, MD PhD · Medical University of Vienna

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05398952 on ClinicalTrials.gov